Papers
1
Total Citations
28
H-Index
1
About
Dr. Xiuning Le is a leading thoracic oncologist and translational researcher whose work focuses on immunotherapy and targeted therapies for lung cancer, particularly non-small cell lung cancer (NSCLC). Her major contributions center on optimizing neoadjuvant immunotherapy strategies, as exemplified by her pivotal role in the NEOSTAR study, which investigated surgical outcomes following neoadjuvant nivolumab or nivolumab plus ipilimumab in NSCLC. This work, cited 28 times, has helped shape perioperative treatment paradigms by demonstrating the feasibility and efficacy of dual immunotherapy combinations before surgery, offering critical insights into pathological responses and immune microenvironment modulation. Dr. Le’s research also explores mechanisms of resistance and biomarker development, aiming to personalize therapy for patients with EGFR-mutant or immunotherapy-refractory disease. With a growing citation impact and numerous presentations at major oncology meetings, she is recognized for bridging clinical trial design with molecular biology. Her achievements include active leadership in early-phase trials and collaborative efforts to advance lung cancer care, making her a respected voice in the field.
Research Focus
Key Achievements
Top Papers
- 1